Cagrilintide is a novel amylin-analog peptide currently under investigation for its potential in weight management applications. This white lyophilized powder offers researchers a high-purity compound for scientific studies.
The product has shown promise in clinical trials when used in combination with GLP-1 agonists for sustained weight reduction in individuals with obesity. Its mechanism of action involves both homeostatic and hedonic brain pathways to promote satiety.
Our Cagrilintide powder is manufactured under strict quality control standards to ensure consistency and purity for research applications. The product is provided in lyophilized form for easy reconstitution and use in laboratory settings.
Key research applications include:
For laboratory use only. Not for human consumption.